Harbour Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Harbour Investments's GILD Position: Q2 2026 in Review
Harbour Investments reduced its Gilead Sciences (GILD) stake by 6.9% in Q2 2026, selling an estimated $217K and leaving 22,237 shares worth $2.81M. The position accounts for 0.04% of the portfolio, ranked #437.
Harbour Investments first reported a position in GILD in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.33M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Harbour Investments held 22,237 shares of Gilead Sciences worth $2.81M as of Q2 2026.
- Harbour Investments sold 1,647 Gilead Sciences shares in Q2 2026, an estimated $217K.
- Gilead Sciences made up 0.04% of Harbour Investments's portfolio in Q2 2026, its #437 holding.
- Harbour Investments first reported a position in Gilead Sciences in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's Gilead Sciences position peaked at $3.33M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.